In addition, ALKBH5 functions as a Pivotal independent prognostic marker in acute myeloid leukemia, with its overexpression associating with unfavorable clinical Outcomes and persistence of leukemia stem cells, thereby implicating its role in therapeutic resistance and disease progression. This evidence concerns the gene ALKBH5 and leukemia.